Eugia Pharma Specialities Limited - Charges

Every charge - open or closed - that lenders have registered against Eugia Pharma Specialities Limited, with the most recent activity at the…

2013-04-17 Ameerpet, Telangana Active Unlisted Active Compliant
Share
View plans
EP Eugia Pharma Specialities Limited
Open charges
0
0.00
Closed charges
3
724.00 cr
Total
3
724.00 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Others 2 605.00 cr
2 Export Import Bank Of India 1 119.00 cr
All charges (3) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
100295568 Others 27 Sep 2019 03 Aug 2021 04 Mar 2022 105.00 cr Closed
100114100 Others 06 Jul 2017 03 Dec 2018 25 Nov 2020 500.00 cr Closed
10481778 Export Import Bank Of India 24 Feb 2014 24 Feb 2014 12 Jul 2017 119.00 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Eugia Pharma Specialities Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Eugia Pharma Specialities Limited (CIN: U24297TG2013PLC087048). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Eugia Pharma Specialities Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.